| Financial Year |
March 31 2023 |
| Monetary Funds |
990,954,558.30 |
| Held-for-trading Financial Assets |
406,005,544.59 |
| Notes Receivable |
29,479,331.18 |
| Accounts Receivable |
621,486,364.70 |
| Advances to Suppliers |
58,198,342.24 |
| Other Receivables |
40,298,908.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
3,200,000.00 |
| Inventories |
1,075,531,831.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
105,854,187.39 |
| Total Current Assets |
3,337,050,693.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
135,075,676.28 |
| Investment Properties |
-- |
| Fixed Assetes |
2,770,808,347.76 |
| Under-construction Projects |
463,187,338.59 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
803,316,948.86 |
| R&D expenses |
-- |
| Goodwill |
144,241,404.14 |
| Long-Term Deferred and Prepaid Expenses |
2,151,936.12 |
| Deferred Income Tax Assets |
23,102,988.37 |
| Other Non-Current Assets |
53,747,508.05 |
| Sub-Total of Non-Current Assets |
4,503,970,880.89 |
| Total Assets |
7,841,021,574.43 |
| Short-Term Loans |
1,505,601,743.14 |
| Trading Financial liabilities |
-- |
| Notes Payable |
498,000,000.00 |
| Accounts Payable |
449,886,481.22 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
79,776,169.37 |
| Taxes Payable |
29,634,211.91 |
| Interest Payable |
2,416,362.75 |
| Dividend Payable |
-- |
| Other payables |
32,342,977.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
204,319,261.90 |
| Other Current Liabilities |
29,431,986.48 |
| Sub-Total of Current Liabilities |
2,894,410,253.71 |
| Long-term Loans |
380,423,805.56 |
| Bonds Payable |
603,738,256.19 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
466,313.25 |
| Deferred Income Tax Liabilities |
84,302,732.04 |
| Other Non-Current Liabilities |
44,749,031.82 |
| Sub-Total of Non-Current Liabilities |
1,129,307,792.21 |
| Total Liabilities |
4,023,718,045.92 |
| Paid-In Capital(Or Share Stock) |
822,569,997.00 |
| Capital Surplus |
1,064,883,911.17 |
| Surplus Reserve |
392,239,120.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,485,023,732.81 |
| Minority Stockholder's Interest |
46,182,974.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,771,120,554.08 |
| Owner's Equity（Stockholder's Equity） |
3,817,303,528.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,841,021,574.43 |
